{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:11:34Z","timestamp":1740136294491,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"crossref","award":["LP120200623"],"award-info":[{"award-number":["LP120200623"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Queensland Government Smart State Research Facilities Programme"},{"name":"National Collaborative Research Infrastructure Strategy program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10787-018-00551-8","type":"journal-article","created":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T15:13:05Z","timestamp":1546355585000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment and characterisation of a stavudine (d4T)-induced rat model of antiretroviral toxic neuropathy (ATN) using behavioural and pharmacological methods"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-3114","authenticated-orcid":false,"given":"Andy","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet R.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2281-3734","authenticated-orcid":false,"given":"Maree T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,1]]},"reference":[{"key":"551_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jana.2009.10.003","volume":"21","author":"BE Aouizerat","year":"2010","unstructured":"Aouizerat BE et al (2010) Risk factors and symptoms associated with pain in HIV-infected adults. J Assoc Nurses AIDS Care JANAC 21:125\u2013133. \n                    https:\/\/doi.org\/10.1016\/j.jana.2009.10.003","journal-title":"J Assoc Nurses AIDS Care JANAC"},{"key":"551_CR2","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/cix848","volume":"65","author":"RD Bruce","year":"2017","unstructured":"Bruce RD et al (2017a) 2017 HIV medicine association of infectious diseases society of America clinical practice guideline for the management of chronic pain in patients living with human immunodeficiency virus. Clin Infect Dis 65:1601\u20131606. \n                    https:\/\/doi.org\/10.1093\/cid\/cix848","journal-title":"Clin Infect Dis"},{"key":"551_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix636","volume":"65","author":"RD Bruce","year":"2017","unstructured":"Bruce RD et al (2017b) 2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clin Infect Dis 65:e1\u2013e37. \n                    https:\/\/doi.org\/10.1093\/cid\/cix636","journal-title":"Clin Infect Dis"},{"key":"551_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/fvl.14.28","volume":"9","author":"TH Burdo","year":"2014","unstructured":"Burdo TH, Miller AD (2014) Animal models of HIV peripheral neuropathy. Future Virol 9:465\u2013474. \n                    https:\/\/doi.org\/10.2217\/fvl.14.28","journal-title":"Future Virol"},{"key":"551_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363","journal-title":"J Neurosci Methods"},{"key":"551_CR6","first-page":"143","volume":"25","author":"CO Cunningham","year":"2018","unstructured":"Cunningham CO (2018) Opioids and HIV infection: from pain management to addiction treatment. Top Antivir Med 25:143\u2013146","journal-title":"Top Antivir Med"},{"issue":"Suppl 2","key":"551_CR7","first-page":"58","volume":"88","author":"JA DeLeo","year":"2006","unstructured":"DeLeo JA (2006) Basic science of pain. J Bone Jt Surg 88(Suppl 2):58\u201362","journal-title":"J Bone Jt Surg"},{"key":"551_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1099800409332726","volume":"11","author":"SG Dorsey","year":"2009","unstructured":"Dorsey SG, Leitch CC, Renn CL, Lessans S, Smith BA, Wang XM, Dionne RA (2009) Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathy. Biol Res Nurs 11:7\u201316. \n                    https:\/\/doi.org\/10.1177\/1099800409332726","journal-title":"Biol Res Nurs"},{"key":"551_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85:S3\u201314. \n                    https:\/\/doi.org\/10.4065\/mcp.2009.0649","journal-title":"Mayo Clin Proc"},{"key":"551_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4065\/81.2.213","volume":"81","author":"S Ferrari","year":"2006","unstructured":"Ferrari S, Vento S, Monaco S, Cavallaro T, Cainelli F, Rizzuto N, Temesgen Z (2006) Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc 81:213\u2013219. \n                    https:\/\/doi.org\/10.4065\/81.2.213","journal-title":"Mayo Clin Proc"},{"key":"551_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162\u2013173. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"551_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3109\/10915819109078660","volume":"10","author":"GC Haggerty","year":"1991","unstructured":"Haggerty GC (1991) Strategy for and experience with neurotoxicity testing of new pharmaceuticals. J Am Coll Toxicol 10:677\u2013688. \n                    https:\/\/doi.org\/10.3109\/10915819109078660","journal-title":"J Am Coll Toxicol"},{"key":"551_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1517\/14656566.8.5.679","volume":"8","author":"A Hill","year":"2007","unstructured":"Hill A et al (2007) Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opin Pharmacother 8:679\u2013688. \n                    https:\/\/doi.org\/10.1517\/14656566.8.5.679","journal-title":"Expert Opin Pharmacother"},{"key":"551_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pain.2012.12.023","volume":"154","author":"W Huang","year":"2013","unstructured":"Huang W et al (2013) A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy. Pain 154:560\u2013575. \n                    https:\/\/doi.org\/10.1016\/j.pain.2012.12.023","journal-title":"Pain"},{"key":"551_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pain.2003.10.010","volume":"107","author":"EK Joseph","year":"2004","unstructured":"Joseph EK, Chen X, Khasar SG, Levine JD (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107:147\u2013158","journal-title":"Pain"},{"key":"551_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1529-8027.2012.00373.x","volume":"17","author":"PR Kamerman","year":"2012","unstructured":"Kamerman PR, Moss PJ, Weber J, Wallace VC, Rice AS, Huang W (2012) Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 17:19\u201331. \n                    https:\/\/doi.org\/10.1111\/j.1529-8027.2012.00373.x","journal-title":"J Peripher Nerv Syst"},{"key":"551_CR17","first-page":"60","volume":"5","author":"KD Kieburtz","year":"1992","unstructured":"Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F (1992) Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr 5:60\u201364","journal-title":"J Acquir Immune Defic Syndr"},{"key":"551_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12972","author":"A Kuo","year":"2018","unstructured":"Kuo A, Smith MT (2018) In vivo profiling of four centrally administered opioids for antinociception, constipation and respiratory depression: between-colony differences in Sprague Dawley rats. Clin Exp Pharmacol Physiol. \n                    https:\/\/doi.org\/10.1111\/1440-1681.12972","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"551_CR100","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fmicb.2016.00103","volume":"7","author":"B Liu","year":"2016","unstructured":"Liu B, Liu X, Tang SJ (2016) Interactions of opioids and HIV infection in the pathogenesis of chronic pain. Front Microbiol 7:103. \n                    https:\/\/doi.org\/10.3389\/fmicb.2016.00103","journal-title":"Front Microbiol"},{"key":"551_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.NURSE.0000513611.64023.0b","volume":"47","author":"A Mello","year":"2017","unstructured":"Mello A, Gravel T (2017) HIV pain management challenges and alternative therapies. Nursing 47:67\u201370. \n                    https:\/\/doi.org\/10.1097\/01.NURSE.0000513611.64023.0b","journal-title":"Nursing"},{"key":"551_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd010902.pub2","author":"RA Moore","year":"2015","unstructured":"Moore RA, Chi CC, Wiffen PJ, Derry S, Rice AS (2015a) Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd010902.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"551_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd008242.pub3","author":"RA Moore","year":"2015","unstructured":"Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (2015b) Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd008242.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"551_CR22","first-page":"335","volume":"11","author":"VC Moser","year":"1990","unstructured":"Moser VC, MacPhail RC (1990) Comparative sensitivity of neurobehavioral tests for chemical screening. Neurotoxicology 11:335\u2013344","journal-title":"Neurotoxicology"},{"key":"551_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2014.11.024","volume":"95","author":"F Nasirinezhad","year":"2015","unstructured":"Nasirinezhad F, Jergova S, Pearson JP, Sagen J (2015) Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. Neuropharmacology 95:100\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2014.11.024","journal-title":"Neuropharmacology"},{"key":"551_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s13365-017-0532-1","volume":"23","author":"HG Ngassa Mbenda","year":"2017","unstructured":"Ngassa Mbenda HG, Wadley A, Lombard Z, Cherry C, Price P, Kamerman P (2017) Genetics of HIV-associated sensory neuropathy and related pain in Africans. J Neurovirol 23:511\u2013519. \n                    https:\/\/doi.org\/10.1007\/s13365-017-0532-1","journal-title":"J Neurovirol"},{"key":"551_CR25","volume-title":"Australian code for the care and use of animals for scientific purposes","author":"NHMRC","year":"2013","unstructured":"NHMRC (2013) Australian code for the care and use of animals for scientific purposes, 8th edn. Australian Government, Canberra","edition":"8"},{"key":"551_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jana.2014.01.002","volume":"25","author":"PK Nicholas","year":"2014","unstructured":"Nicholas PK, Corless IB, Evans LA (2014) Peripheral neuropathy in HIV: an analysis of evidence-based approaches. J Assoc Nurses AIDS Care 25:318\u2013329. \n                    https:\/\/doi.org\/10.1016\/j.jana.2014.01.002","journal-title":"J Assoc Nurses AIDS Care"},{"key":"551_CR27","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.pain.2014.06.014","volume":"155","author":"TJ Phillips","year":"2014","unstructured":"Phillips TJ et al (2014) Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: a cross-sectional deep profiling study. Pain 155:1846\u20131860. \n                    https:\/\/doi.org\/10.1016\/j.pain.2014.06.014","journal-title":"Pain"},{"key":"551_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.7196\/SAMJnew.7908","volume":"105","author":"P Pillay","year":"2015","unstructured":"Pillay P, Wadley AL, Cherry CL, Karstaedt AS, Kamerman PR (2015) Pharmacological treatment of painful HIV-associated sensory neuropathy. S Afr Med J 105:769\u2013772. \n                    https:\/\/doi.org\/10.7196\/SAMJnew.7908","journal-title":"S Afr Med J"},{"key":"551_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/HIV.S36674","volume":"5","author":"SG Schutz","year":"2013","unstructured":"Schutz SG, Robinson-Papp J (2013) HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) 5:243\u2013251. \n                    https:\/\/doi.org\/10.2147\/HIV.S36674","journal-title":"HIV AIDS (Auckl)"},{"key":"551_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s11055-015-0140-6","volume":"45","author":"SE Serdyuk","year":"2015","unstructured":"Serdyuk SE, Gmiro VE (2015) Mesaton (phenylephrine) potentiates the antidepressant and eliminates the sedative action of amitriptyline in rats. Neurosci Behav Physiol 45:760\u2013764. \n                    https:\/\/doi.org\/10.1007\/s11055-015-0140-6","journal-title":"Neurosci Behav Physiol"},{"key":"551_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fphar.2017.00442","volume":"8","author":"P Shenoy","year":"2017","unstructured":"Shenoy P, Kuo A, Vetter I, Smith MT (2017) Optimization and in vivo profiling of a refined rat model of walker 256 breast cancer cell-induced bone pain using behavioral, radiological, histological, immunohistochemical and pharmacological methods. Front Pharmacol 8:442. \n                    https:\/\/doi.org\/10.3389\/fphar.2017.00442","journal-title":"Front Pharmacol"},{"key":"551_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ncl.2009.09.018","volume":"28","author":"EJ Singer","year":"2010","unstructured":"Singer EJ, Valdes-Sueiras M, Commins D, Levine A (2010) Neurologic presentations of AIDS. Neurol Clin 28:253\u2013275. \n                    https:\/\/doi.org\/10.1016\/j.ncl.2009.09.018","journal-title":"Neurol Clin"},{"key":"551_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81:772\u2013781. \n                    https:\/\/doi.org\/10.1002\/ana.24951","journal-title":"Ann Neurol"},{"key":"551_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2165\/00023210-200519040-00005","volume":"19","author":"S Verma","year":"2005","unstructured":"Verma S, Estanislao L, Simpson D (2005) HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs 19:325\u2013334","journal-title":"CNS Drugs"},{"key":"551_CR35","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/rheumatology\/kex062.185","volume":"56","author":"K Walker-Bone","year":"2017","unstructured":"Walker-Bone K, Doherty E, Sanyal K, Churchill D (2017) Assessment and management of musculoskeletal disorders among patients living with HIV. Rheumatology (Oxford) 56:1648\u20131661. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kew418","journal-title":"Rheumatology (Oxford)"},{"key":"551_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pain.2007.02.015","volume":"133","author":"VC Wallace","year":"2007","unstructured":"Wallace VC et al (2007) Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 133:47\u201363. \n                    https:\/\/doi.org\/10.1016\/j.pain.2007.02.015","journal-title":"Pain"},{"key":"551_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.physbeh.2007.06.005","volume":"92","author":"J Weber","year":"2007","unstructured":"Weber J, Mitchell D, Kamerman PR (2007) Oral administration of stavudine induces hyperalgesia without affecting activity in rats. Physiol Behav 92:807\u2013813. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2007.06.005","journal-title":"Physiol Behav"},{"key":"551_CR38","unstructured":"WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. In: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. WHO Guidelines Approved by the Guidelines Review Committee, Geneva"},{"key":"551_CR39","unstructured":"WHO (2018) WHO Global Health Observatory data\u2014HIV\/AIDS. WHO. \n                    http:\/\/www.who.int\/gho\/hiv\/en\/\n                    \n                  . Accessed 23 Aug 2018"},{"key":"551_CR40","doi-asserted-by":"publisher","first-page":"CD007938","DOI":"10.1002\/14651858.cd007938.pub4","volume":"6","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Derry S, Bell RF, Rice AS, Tolle TR, Phillips T, Moore RA (2017) Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 6:CD007938. \n                    https:\/\/doi.org\/10.1002\/14651858.cd007938.pub4","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-00551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-00551-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-00551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T21:34:59Z","timestamp":1589664899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-00551-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-00551-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2019,1,1]]},"assertion":[{"value":"17 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no relevant conflicts of interest to declare in association with this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}